Tvardi Therapeutics Q3 EPS $(0.48) Beats $(0.53) Estimate
Benzinga Newsdesk 14 hours ago
NewsEarningsEarnings Beats
Tvardi Therapeutics (NASDAQ:TVRD) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.53) by 9.43 percent. This is a 18.64 percent increase over losses of $(0.59) per share
Tvardi Therapeutics (NASDAQ:TVRD) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.53) by 9.43 percent. This is a 18.64 percent increase over losses of $(0.59) per share from the same period last year.